Purchase Order 75F40124P00427

Award Date 9/18/24
Potential Completion Date 9/17/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Irvine, CA 92612, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $99,703.17 firm fixed-price purchase order contract was awarded by the Food and Drug Administration (FDA) to Charles River Laboratories, Inc. The contract is for the delivery of a rapid analyzer and services related to endotoxin contamination testing. The contract does not have a set-aside designation. Charles River Laboratories is a global contract research organization that provides a wide range of products and services to support government biomedical research and development efforts....
This is a $14,155.30 firm fixed-price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency, to Charles River Laboratories, Inc. The contract is not set aside. Charles River Laboratories is a global contract research organization that provides essential products and services to support pharmaceutical, biotechnology, and government research and development efforts. The contract covers the period from July 3, 2025 to July 2, 2026....
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Charles River Laboratories, Inc. for the CHARLES RIVER LABORATORIES ENDOSAFE NEXGEN MCS PACKAGE AND MATERIALS. The contract has a ceiling value of $21,111.70 and a performance period ending on February 28, 2025. Charles River Laboratories is a global contract research organization that provides essential products and services to support...
This is a federal contract award to Charles River Laboratories, Inc. (doing business as Charles River), a global contract research organization that provides essential products and services to support pharmaceutical, biotechnology, and government research and development efforts. The contract, awarded by the Office of the Director, is a Delivery Order with a ceiling value of $635,500.00 and a pricing type of Time and Materials. It has an ultimate completion date of February 28, 2025. The...
This is a firm fixed-price delivery order contract awarded by the Office of the Director, a civilian federal agency, to Charles River Laboratories, Inc. (Charles River) for $681,557.15. The contract is for contract services from June 1, 2015 to May 31, 2016, with a final completion date of July 31, 2018. The contract does not have a set-aside designation. Charles River is a global contract research organization that provides essential products and services to support pharmaceutical,...
This is a $435,108.00 firm fixed-price delivery order awarded to Charles River Laboratories, Inc. by the Office of the Director, a civilian federal agency. The contract has an ultimate completion date of August 11, 2025 and was awarded on August 12, 2019. Charles River Laboratories is a global contract research organization that provides essential products and services to support pharmaceutical, biotechnology, and government research and development efforts. The contract award does not...
This is a federal contract award to Charles River Laboratories, Inc., a global contract research organization, by the Office of Logistics and Acquisition Operations, a civilian federal agency. The contract has a ceiling value of $749,000.00 and is a Delivery Order under a Time and Materials pricing type. The contract supports the agency's research and development efforts, with Charles River providing specialized research products and services such as laboratory animal procurement and...
This is a $8,232 firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Charles River Laboratories, Inc. (Charles River) on February 27, 2019. The contract has an ultimate completion date of February 26, 2025 and does not utilize a set-aside designation. Charles River is a global contract research organization that provides essential products and services to support pharmaceutical, biotechnology, and government research and development...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Charles River Laboratories, Inc. for sterility testing of final containers and biological products. The contract has a ceiling value of $18,300.00 and a completion date of August 5, 2025. Charles River Laboratories is a global contract research organization that provides specialized research products and services to government agencies. This...
This is a firm fixed-price delivery order contract awarded to Charles River Laboratories, Inc. (Charles River) by a civilian federal agency, the Office of the Director. The contract has a ceiling value of $78,000.00 and a completion date of January 31, 2013. Charles River is a global contract research organization that provides specialized research products and services to support government research and development efforts. This contract does not have a set-aside designation, indicating Charles...

This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Charles River Laboratories, Inc. for the Endoscan-V software upgrade to version 6. The contract has a ceiling value of $11,049.00 and a period of performance through September 17, 2025. The software upgrade is being procured through a sole source contract under NAICS code 334516. No set-aside designation was used. Charles River Laboratories is a global contract research organization that provides a wide range of specialized products and services to support biomedical research and public health initiatives for federal agencies. This contract aligns with the FDA's mission to regulate medical products and ensure their safety and efficacy.

Generated 4/1/25, 3:48 PM